Skip to main content
. 2020 Jun 4;8(3):e00604. doi: 10.1002/prp2.604

Figure 2.

Figure 2

Binding affinity of FKB327, US‐licensed adalimumab reference product, and EU‐approved adalimumab reference product to soluble TNF‐α. KD, equilibrium dissociation constant; rh, recombinant human; RP, reference product (Humira®); SPR, surface plasmon resonance; TNF‐α, tumor necrosis factor alpha